Pier 88 Investment Partners’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$800K Buy
57,150
+12,240
+27% +$171K 0.15% 65
2025
Q1
$611K Sell
44,910
-500
-1% -$6.8K 0.12% 80
2024
Q4
$925K Sell
45,410
-13,760
-23% -$280K 0.18% 56
2024
Q3
$1.72M Sell
59,170
-10,200
-15% -$297K 0.38% 36
2024
Q2
$1.61M Buy
69,370
+29,400
+74% +$683K 0.36% 42
2024
Q1
$820K Sell
39,970
-5,270
-12% -$108K 0.2% 46
2023
Q4
$971K Sell
45,240
-5,460
-11% -$117K 0.24% 54
2023
Q3
$1.05M Buy
50,700
+3,020
+6% +$62.3K 0.26% 63
2023
Q2
$1.41M Buy
47,680
+4,840
+11% +$143K 0.35% 51
2023
Q1
$987K Buy
42,840
+7,600
+22% +$175K 0.24% 55
2022
Q4
$980K Buy
35,240
+23,150
+191% +$644K 0.24% 54
2022
Q3
$371K Sell
12,090
-990
-8% -$30.4K 0.09% 79
2022
Q2
$385K Buy
13,080
+13,070
+130,700% +$385K 0.09% 85
2022
Q1
$0 Sell
10
-33,070
-100% ﹤0.01% 90
2021
Q4
$1.48M Buy
33,080
+14,200
+75% +$634K 0.31% 64
2021
Q3
$952K Buy
18,880
+4,760
+34% +$240K 0.29% 73
2021
Q2
$1.11M Buy
14,120
+6,560
+87% +$515K 0.32% 74
2021
Q1
$432K Sell
7,560
-5,265
-41% -$301K 0.15% 98
2020
Q4
$1.07M Sell
12,825
-22,970
-64% -$1.92M 0.35% 53
2020
Q3
$1.28M Sell
35,795
-16,514
-32% -$591K 0.39% 53
2020
Q2
$1.27M Buy
52,309
+4,609
+10% +$111K 0.36% 69
2020
Q1
$835K Buy
47,700
+5,700
+14% +$99.8K 0.3% 57
2019
Q4
$732K Buy
42,000
+1,390
+3% +$24.2K 0.29% 47
2019
Q3
$622K Buy
40,610
+12,960
+47% +$199K 0.24% 65
2019
Q2
$574K Sell
27,650
-8,280
-23% -$172K 0.24% 70
2019
Q1
$834K Buy
35,930
+9,800
+38% +$227K 0.38% 48
2018
Q4
$540K Sell
26,130
-11,800
-31% -$244K 0.27% 52
2018
Q3
$825K Buy
+37,930
New +$825K 0.36% 41